Compliance therapy: a randomised controlled trial in schizophrenia. - Wikidata - awgldk - TriplyDB

Compliance therapy: a randomised controlled trial in schizophrenia.

Compliance therapy: a randomised controlled trial in schizophrenia.

http://www.wikidata.org/entity/Q36274868

about

Cognitive behavioural therapy (brief versus standard duration) for schizophrenia Interventions for enhancing medication adherence Cognitive behavioural therapy (brief versus standard duration) for schizophrenia Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia Interventions for enhancing medication adherence Compliance therapy for schizophrenia Helping to prioritise interventions for depression and schizophrenia: use of Population Impact Measures An approach to maximizing treatment adherence of children and adolescents with psychotic disorders and major mood disorders Medication adherence in schizophrenia Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review.The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review.Attitudes to antipsychotic drugs and their side effects: a comparison between general practitioners and the general population.Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trial Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study.A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.Acceptability of offering financial incentives to achieve medication adherence in patients with severe mental illness: a focus group study.Insight and its relationship with stigma in psychiatric patients.How to formulate research recommendations Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial The Promises and Challenges of Ecological Momentary Assessment in Schizophrenia: Development of an Initial Experimental Protocol Defining and assessing adherence to oral antipsychotics: a review of the literature The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.Managing non-adherence and the 3 Cs: collaboration, cash and coercion.Perceptions around concordance--focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners.Tackling nonadherence in psychiatric disorders: current opinion.Community psychiatry's achievements.Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?Mental health: patients' experiences of patient education during inpatient care.Effect of a system-oriented intervention on compliance problems in schizophrenia: a pragmatic controlled trial.Improving medication adherence in rheumatoid arthritis (RA): a pilot study.Effectiveness of adherence therapy in patients with early psychosis: a mirror image study.Enhancing patient adherence: outcomes of medication alliance training on therapeutic alliance, insight, adherence, and psychopathology with mental health patients.The effectiveness of booster sessions in CBT treatment for child and adolescent mood and anxiety disorders.A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.Vestibular stimulation improves insight into illness in schizophrenia spectrum disorders.Schizophrenia should be renamed to help educate patients and the public.

P2860

Q24186426-796310E4-74D6-4D5E-9F67-E3A087F2DBA9 Q24187912-581D631E-E28F-4FC6-96A1-31F423347F54 Q24195092-5DE8A824-9449-4A11-BB6C-37A91696F80E Q24200364-5C413B8D-A0BD-4133-99F6-85905D530D4F Q24235301-68C43FB3-F431-4889-9247-7CF857F44D31 Q24243296-1B59D6EB-4BF9-41FB-AA43-E4F3A9591B4B Q24244947-B23993F0-BF4B-4450-BEC4-1E6ADA96103E Q24547993-009301F6-75F2-4369-88CB-5CF969315151 Q24644760-3CFEC31F-D759-45EB-90EA-8F3F73152FFA Q26823655-B86926F4-70D8-40BF-AD28-0CEEA4C65BEE Q30317036-E1E044F0-0DF2-4CDD-BBAD-5FBF99F59AFD Q30530398-6207A74A-AAD4-4809-B960-BB8EF8CCBC05 Q33260765-87F77FB2-104F-4F4C-A7A3-475168264D39 Q33290999-37D0F23B-B182-436A-876D-B0A3702570BB Q33464064-BB4CA465-2445-42EF-8CC6-97B5B5FDA7F9 Q33500672-86217978-8B34-4FD7-B3F5-63371BC729CA Q33857710-0FD0F02A-65CA-474A-B54C-1C653D7D1692 Q34292011-F04F3B14-6053-4921-A20D-651869462998 Q34469615-3EF57A3A-25CA-4C6A-94C7-0E60F1A01B4A Q35082894-B1F1961F-6432-4217-8F96-559385FA9E18 Q35747635-5D17C950-BF81-4B0B-B5D1-86F6D4106429 Q35934587-F1633019-2912-413A-A4F7-F1D146DF088B Q36383958-A7A72287-D48B-428A-BD62-01574CD9A3F8 Q36481418-DBE64B29-CE15-4AD9-B2F2-75CC9F01462E Q37228370-E78B7ED3-F77E-4392-A816-2FDA52EDFEB8 Q37236148-278F1CF7-0609-43C4-BABA-3355312187D9 Q37236155-DE5C8122-5429-4FB6-95A3-899FE8784788 Q37331737-EF42C19C-1A47-4958-B127-FF0AD695C17C Q38223376-07CC6122-4C70-4A17-9402-7901064F6BBA Q38250372-07ED9223-0CE4-47EB-AB72-60AB577D5783 Q40019621-BB9A590F-1AEA-4865-855C-53245EAF325F Q40123317-ED732F75-C2A5-40D1-8962-E125977A83C2 Q40785183-68523D4C-24A4-4BFE-BAE4-FDE02FBF5320 Q41213036-09D8DA5A-79A0-4610-BC8A-B00645848575 Q44616517-7644503A-C0A9-46F4-987C-4E33FD74824F Q46180105-FE598947-73A6-430C-920B-062F412F2F5F Q46711007-66AA2ACE-F586-4927-9B3C-942D9C44B40E Q47650574-372B4192-68A6-490F-BC89-4F1016D7BADF Q47791164-6AD53998-0D09-4885-AFF1-07EAF7743876 Q48293639-70356829-2B6F-4C0B-A522-8CD3C1DE72F1

P2860

Compliance therapy: a randomised controlled trial in schizophrenia.

http://www.wikidata.org/entity/Q36274868

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Compliance therapy: a randomised controlled trial in schizophrenia.

@ast

Compliance therapy: a randomised controlled trial in schizophrenia.

@en

type

label

Compliance therapy: a randomised controlled trial in schizophrenia.

@ast

Compliance therapy: a randomised controlled trial in schizophrenia.

@en

prefLabel

Compliance therapy: a randomised controlled trial in schizophrenia.

@ast

Compliance therapy: a randomised controlled trial in schizophrenia.

@en

P1433

Q36274868-662E1A58-290C-44D6-B813-5AA2965433C9

P1476

Q36274868-AEC86C86-3029-4204-90DE-9C9EF57E29B5

P2093

Q36274868-0512A618-78E3-4D5A-BD56-A82C6E613CE2

Q36274868-2417A535-AE0F-4654-8642-53D50B9008B5

Q36274868-572B7FF0-9A1C-41F7-BF76-16E0B9121DA4

Q36274868-80CEB4E9-8F05-4BD0-875E-7F7064BFAE3F

Q36274868-9F07FE55-51A4-403A-BBA4-41E662E6E265

Q36274868-C8E9C30D-B791-4F73-A710-7EE767A39408

Q36274868-D0404D01-3E40-4732-A361-5B9A9D7CEDCF

Q36274868-F5FAA504-F4A1-4EC6-9703-CE23234F39F2

P2860

Q36274868-18EB3F24-8D7C-44F4-9EFC-237837722DF6

Q36274868-38D83770-E93C-4C65-AA69-47F645EA101B

Q36274868-48EAC57E-54F1-4462-833B-CAA7FC6ADBF9

Q36274868-73763120-0E42-4630-B2A7-BC83D40BB8BB

Q36274868-8DBFA3C3-8E3F-461A-B447-FC4D8453CD49

Q36274868-94FF24F0-13C8-4678-85A0-E90C1ECBC874

Q36274868-AAD7D176-573F-427D-BA85-BC1BDE58FD44

Q36274868-B454F977-8A17-4AFD-9DCA-CB25F68881BA

Q36274868-CD4F15AF-736D-4EAC-9E00-585165C7D886

Q36274868-E7198B21-43F6-4109-9157-C9EA2C8066E0

P304

Q36274868-0093D049-BBDA-4801-A7F8-052F3E3C6D43

P31

Q36274868-339F3D3F-F40C-484F-A917-3995AC3B668F

P356

Q36274868-CE57A4B3-BAE3-459C-9454-852748DB275D

P407

Q36274868-962FB006-7F7F-4913-8F8B-EA622879C32B

P433

Q36274868-EC3EC964-67B9-4375-AA53-BEED385FA44B

P478

Q36274868-B9CC7F54-412C-45EA-B56A-37D554C509DF

P50

Q36274868-E2350C7C-3402-49CA-8398-A80356A8E885

P577

Q36274868-99BF75DB-F4FD-454D-9413-69602548EBD0

P5875

Q36274868-2372033C-89D1-45DD-B77A-EAAD4090EDE3

P698

Q36274868-7FA23132-9122-4D46-8FC5-00647F3A18BF

P921

Q36274868-8D986ACC-50E5-4491-91FF-3B6B72A19B36

P932

Q36274868-45EF2184-4002-46D1-8917-42C37FCA0EB9

P356

BMJ.327.7419.834

P1433

P1476

Compliance therapy: a randomised controlled trial in schizophrenia.

@en

P2093

Anthony Kinsella

http://www.w3.org/2001/XMLSchema#string

Colin O'Donnell

http://www.w3.org/2001/XMLSchema#string

Conall Larkin

http://www.w3.org/2001/XMLSchema#string

Eadbhard O'Callaghan

http://www.w3.org/2001/XMLSchema#string

Louise Sharkey

http://www.w3.org/2001/XMLSchema#string

Maria Migone

http://www.w3.org/2001/XMLSchema#string

Nicholas Owens

http://www.w3.org/2001/XMLSchema#string

Raewynn Harries

http://www.w3.org/2001/XMLSchema#string

P2860

Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia

Determinants of medication compliance in schizophrenia: empirical and clinical findings

The positive and negative syndrome scale (PANSS) for schizophrenia

Methods of helping patients with behaviour change.

Compliance therapy in psychotic patients: randomised controlled trial.

Insight and psychosis.

Predicting medication compliance in a psychotic population.

Demographic factors associated with extreme non-compliance in schizophrenia.

Biological predictors of suicidality in schizophrenia.

Post-hospitalization treatment adherence of schizophrenic patients: gender differences in skill acquisition.

P304

834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.327.7419.834

http://www.w3.org/2001/XMLSchema#string

P407

P433

7419

http://www.w3.org/2001/XMLSchema#string

P478

327

http://www.w3.org/2001/XMLSchema#string

P50

Gary J. Donohoe

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9056593

http://www.w3.org/2001/XMLSchema#string

P698

14551096

http://www.w3.org/2001/XMLSchema#string

P921

P932

214016

http://www.w3.org/2001/XMLSchema#string